Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]

Volume 12, Issue 6, December 2022, Page 937

Author links open overlay panelLeonnyDwi RizkitaIndwianiAstutiPersonEnvelopeShow moreNavigate DownNavigate LeftPrevious article in issueNext article in issueNavigate Right

More from this channel

Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]

留言 (0)